Your browser doesn't support javascript.
loading
Intra-arterial idarubicin_lipiodol without embolisation in hepatocellular carcinoma: The LIDA-B phase I trial.
Guiu, Boris; Jouve, Jean-Louis; Schmitt, Antonin; Minello, Anne; Bonnetain, Franck; Cassinotto, Christophe; Piron, Lauranne; Cercueil, Jean-Pierre; Loffroy, Romaric; Latournerie, Marianne; Wendremaire, Maëva; Lepage, Côme; Boulin, Mathieu.
Afiliación
  • Guiu B; Department of Interventional Radiology, INSERM U1194, St-Eloi University Hospital, Montpellier School of Medicine, 80 Avenue Augustin Fliche, 34295 Montpellier, France. Electronic address: b-guiu@chu-montpellier.fr.
  • Jouve JL; Department of Hepatogastroenterology, Dijon University Hospital and EPICAD LNC-UMR1231, Burgundy & Franche Comté University, BP 87900, 21079 Dijon, France.
  • Schmitt A; Department of Pharmacy, Georges-François Leclerc Anticancer Centre and LNC-UMR1231, Burgundy & Franche Comté University, BP 87900, 21079 Dijon, France.
  • Minello A; Department of Hepatogastroenterology, Dijon University Hospital and EPICAD LNC-UMR1231, Burgundy & Franche Comté University, BP 87900, 21079 Dijon, France.
  • Bonnetain F; Methodology and Quality of Life in Oncology Unit (EA 3181) and Quality of Life and Cancer Clinical Research Platform, University Hospital Besançon, 2 Place Saint Jacques, 25000 Besançon, France.
  • Cassinotto C; Department of Interventional Radiology, INSERM U1194, St-Eloi University Hospital, Montpellier School of Medicine, 80 Avenue Augustin Fliche, 34295 Montpellier, France.
  • Piron L; Department of Interventional Radiology, INSERM U1194, St-Eloi University Hospital, Montpellier School of Medicine, 80 Avenue Augustin Fliche, 34295 Montpellier, France.
  • Cercueil JP; Department of Interventional Radiology, University Hospital, 14 rue Gaffarel, 21000 Dijon, France.
  • Loffroy R; Department of Interventional Radiology, University Hospital, 14 rue Gaffarel, 21000 Dijon, France.
  • Latournerie M; Department of Hepatogastroenterology, Dijon University Hospital and EPICAD LNC-UMR1231, Burgundy & Franche Comté University, BP 87900, 21079 Dijon, France.
  • Wendremaire M; Department of Pharmacology-Toxicology, University Hospital, 2 rue Angélique Ducoudray, 21000 Dijon, France.
  • Lepage C; Department of Hepatogastroenterology, Dijon University Hospital and EPICAD LNC-UMR1231, Burgundy & Franche Comté University, BP 87900, 21079 Dijon, France.
  • Boulin M; Department of Pharmacy, Dijon University Hospital and EPICAD LNC-UMR1231, Burgundy & Franche Comté University, BP 87900, 21079 Dijon, France.
J Hepatol ; 68(6): 1163-1171, 2018 06.
Article en En | MEDLINE | ID: mdl-29427728
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Idarrubicina / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antibióticos Antineoplásicos Aspecto: Patient_preference Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2018 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Idarrubicina / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antibióticos Antineoplásicos Aspecto: Patient_preference Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2018 Tipo del documento: Article Pais de publicación: Países Bajos